Genetic disorders in normally androgenized infertile men and the use of intracytoplasmic sperm injection as a way of treatment

Objective: To determine the incidence of chromosomal abnormalities in normally androgenized infertile men with no other recognized causes of infertility or who had ever been submitted to other unsuccessful methods of treatment. Design: Collaborative retrospective study of clinical experience collected by an endocrinologist and a geneticist over a 5-year period. Setting: Outpatients at an endocrinology clinic. Patient(s): Infertile male patients with azoospermia (n = 23), oligozoospermia (n = 66), and normozoospermia (n = 14) presenting normal (n = 85) or subnormal (n = 18) testicular volume. Intervention(s): All patients were submitted to cytogenetic analysis. Main Outcome Measure(s): Two patients were referred to intracytoplasmic sperm injection (ICSI), and in one case, a successful gemellar pregnancy ended up uneventful. Children's genetic testings were not performed according to parents' request. Result(s): Abnormal karyotypes were found in 11 (10.6%) patients. Chromosomal abnormalities were found in 17.3% of the 23 azoospermic patients, in 10.6% of the 66 oligozoospermic patients, and in none of the 14 normozoospermic patients. These disorders were found only in patients with normal testicular volumes and no more than 10 x 10(6) spermatozoa per mL. Conclusion(s): A high incidence of chromosomal abnormalities was found in a selected group of normally androgenized infertile male patients. The elevated rate of fertilization achieved in one patient indicates that ICSI is, at the moment, the only choice for treatment of male infertility because of chromosomal abnormalities. (C) 1997 by American Society for Reproductive Medicine.